Certificate of AnalysisSDSProduct Catalog Technical Library
Avantor is owned by New Mountain Capital, which acquired the company from Covidien Inc. in 2010.
New Mountain Capital is a New York-based private
equity firm that emphasizes business building and growth, rather than debt, as
it pursues long-term capital appreciation. The firm currently manages private
and public equity funds with approximately $12 billion in aggregate capital
commitments. New Mountain Capital seeks out what it believes to be the
highest-quality growth leaders in carefully selected industry sectors and then
works intensively with management to build the value of these companies.
Our Leadership Team
Avantor’s Executive Leadership Team includes experienced managers and scientists who share a common goal: to build the strength of our global performance and further establish Avantor as a global supplier of ultra-high-purity life sciences materials with strict regulatory and performance specifications.
Chairman of the Board, and Senior Advisor, New Mountain Capital
Chief Financial Officer
Eric McAllisterChief Human Resources Officer
Avantor 3477 Corporate ParkwayCenter Valley, PA 18034U.S.A.Phone: 1-855-AVANTOR(1-855-282-6867)Outside of U.S.: 1-610-573-2600Fax: 1-610-573-2610
Avantor's Global LocationsMedia Inquiries
Avantor® manufactures and markets high-performance materials and solutions around the world. Avantor's products are used in the production and research needs of customers across the biotechnology, pharmaceutical, medical device, diagnostics, aerospace & defense and semiconductor industries. Avantor's proven brands include the J.T.Baker®, NuSil™, Macron Fine Chemicals™, Rankem™, BeneSphera™, POCH™ and CareSil brands.